Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.720 | ||
| Révision: | $209.00M | $182.50M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.480 | 0.470 | -0.0100 |
| Révision: | $207.00M | $230.95M | -$7.30M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.760 | 0.440 | -0.3200 |
| Révision: | $194.00M | $258.20M | -$1.90M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.680 | 0.590 | -0.0900 |
| Révision: | $178.50M | $311.20M | $3.80M |
